Immune Disease | GAMMAGARD LIQUID IGIV

GAMMAGARD LIQUID
[Immune Globulin Intravenous (Human)] 10%

GAMMAGARD LIQUID 10% formulated for a broad spectrum of patients, is the first 10% IVIG solution with the following unique combination of features:

No added sugars¹
No added sodium¹
No added preservatives¹
Latex-free packaging¹

Learn More about GAMMAGARD LIQUID

Additionally, GAMMAGARD LIQUID 10% offers several important formulation, storage, and infusion features¹...

No reconstitution required; the use of an in-line filter is optional
Flexible infusion rate of up to 5.0* mL/kg/hr
5 color-coded dosing sizes
9-month storage at room temperature** within 24 months of the date of processing
36 month-storage when refrigerated***

GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

Please see Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%

To view PDFs, you will need Adobe® Acrobat® Reader® software.

§ 12-month trial among 61 patients with primary immunodeficiency.
* In a pivotal clinical trial^§, mean infusion rate was 4.3 mL/kg/hr; 95% of subjects achieved a maximum rate of 4.0 mL/kg/hr or greater. Of these, 26% attained a rate of 5.0 mL/kg/hr.
** 25 C° (77° F)
*** 2° – 8° C (36°– 46° F)

1. GAMMAGARD LIQUID Immune Globulin Intravenous (Human) 10% [package insert]. Deerfield, IL. Baxter International Inc.; April 2005.

Sign Up Today